Latest Insider Transactions at Travelers Companies, Inc. (TRV)
This section provides a real-time view of insider transactions for Travelers Companies, Inc. (TRV). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of TRAVELERS COMPANIES, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of TRAVELERS COMPANIES, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 31
2022
|
Elizabeth Robinson Director |
BUY
Grant, award, or other acquisition
|
Direct |
184
+3.38%
|
$33,488
$182.73 P/Share
|
Feb 28
2022
|
Douglas K Russell SVP, Corp Contr & Treasurer |
SELL
Open market or private sale
|
Direct |
1,161
-6.21%
|
$199,692
$172.0 P/Share
|
Feb 23
2022
|
Andy F Bessette EVP and Chief Admin Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,632
-15.45%
|
$450,072
$171.5 P/Share
|
Feb 23
2022
|
Andy F Bessette EVP and Chief Admin Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,844
+25.54%
|
-
|
Feb 23
2022
|
Daniel S. Frey EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,214
-42.76%
|
$720,594
$171.5 P/Share
|
Feb 23
2022
|
Daniel S. Frey EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,044
+47.86%
|
-
|
Feb 23
2022
|
William H Heyman Vice Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
7,849
-3.03%
|
$1,342,179
$171.5 P/Share
|
Feb 23
2022
|
William H Heyman Vice Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
14,193
+5.19%
|
-
|
Feb 23
2022
|
Avrohom J. Kess Vice Chmn & Chief Legal Off |
SELL
Payment of exercise price or tax liability
|
Direct |
7,849
-20.2%
|
$1,342,179
$171.5 P/Share
|
Feb 23
2022
|
Avrohom J. Kess Vice Chmn & Chief Legal Off |
BUY
Grant, award, or other acquisition
|
Direct |
14,193
+26.75%
|
-
|
Feb 23
2022
|
Michael Frederick Klein EVP & President, Personal Ins. |
SELL
Payment of exercise price or tax liability
|
Direct |
4,213
-31.63%
|
$720,423
$171.5 P/Share
|
Feb 23
2022
|
Michael Frederick Klein EVP & President, Personal Ins. |
BUY
Grant, award, or other acquisition
|
Direct |
9,044
+40.44%
|
-
|
Feb 23
2022
|
Jeffrey P. Klenk EVP & Pres., Bond & Spec. Ins. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,752
-22.39%
|
$299,592
$171.5 P/Share
|
Feb 23
2022
|
Jeffrey P. Klenk EVP & Pres., Bond & Spec. Ins. |
BUY
Grant, award, or other acquisition
|
Direct |
3,757
+32.44%
|
-
|
Feb 23
2022
|
Diane Kurtzman EVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
402
-18.81%
|
$68,742
$171.5 P/Share
|
Feb 23
2022
|
Diane Kurtzman EVP & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,113
+34.25%
|
-
|
Feb 23
2022
|
Mojgan M Lefebvre EVP & Chief Tech & Ops Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,271
-45.21%
|
$559,341
$171.5 P/Share
|
Feb 23
2022
|
Mojgan M Lefebvre EVP & Chief Tech & Ops Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,235
+50.0%
|
-
|
Feb 23
2022
|
Maria Olivo EVP, Strat Dev & Pres Intl |
SELL
Payment of exercise price or tax liability
|
Direct |
3,621
-3.54%
|
$619,191
$171.5 P/Share
|
Feb 23
2022
|
Maria Olivo EVP, Strat Dev & Pres Intl |
BUY
Grant, award, or other acquisition
|
Direct |
7,235
+6.61%
|
-
|
Feb 23
2022
|
David Donnay Rowland EVP & Co-Chief Invest. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,028
-12.48%
|
$175,788
$171.5 P/Share
|
Feb 23
2022
|
David Donnay Rowland EVP & Co-Chief Invest. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,254
+21.49%
|
-
|
Feb 23
2022
|
Douglas K Russell SVP, Corp Contr & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
968
-4.92%
|
$165,528
$171.5 P/Share
|
Feb 23
2022
|
Douglas K Russell SVP, Corp Contr & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
2,129
+9.77%
|
-
|
Feb 23
2022
|
Alan D Schnitzer Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
27,702
-12.19%
|
$4,737,042
$171.5 P/Share
|
Feb 23
2022
|
Alan D Schnitzer Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
50,092
+18.06%
|
-
|
Feb 23
2022
|
Gregory C Toczydlowski EVP & President, Business Ins. |
SELL
Payment of exercise price or tax liability
|
Direct |
4,543
-19.79%
|
$776,853
$171.5 P/Share
|
Feb 23
2022
|
Gregory C Toczydlowski EVP & President, Business Ins. |
BUY
Grant, award, or other acquisition
|
Direct |
9,739
+29.79%
|
-
|
Feb 23
2022
|
Daniel Tei Hwa Yin EVP & Co-Chief Invest. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,136
-2.37%
|
$194,256
$171.5 P/Share
|
Feb 23
2022
|
Daniel Tei Hwa Yin EVP & Co-Chief Invest. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,254
+4.5%
|
-
|
Feb 15
2022
|
Andy F Bessette EVP and Chief Admin Officer |
SELL
Bona fide gift
|
Direct |
584
-4.96%
|
-
|
Feb 09
2022
|
William H Heyman Vice Chairman |
SELL
Open market or private sale
|
Direct |
2,000
-0.81%
|
$348,000
$174.12 P/Share
|
Feb 09
2022
|
William H Heyman Vice Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+0.8%
|
$236,000
$118.78 P/Share
|
Feb 08
2022
|
Alan L Beller Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,043
+2.58%
|
$179,396
$172.5 P/Share
|
Feb 08
2022
|
Janet M Dolan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,043
+2.02%
|
$179,396
$172.5 P/Share
|
Feb 08
2022
|
Patricia Higgins Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,043
+2.57%
|
$179,396
$172.5 P/Share
|
Feb 08
2022
|
William J Kane Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,043
+4.81%
|
$179,396
$172.5 P/Share
|
Feb 08
2022
|
Thomas B Leonardi Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,043
+32.52%
|
$179,396
$172.5 P/Share
|
Feb 08
2022
|
Clarence Otis Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,043
+7.59%
|
$179,396
$172.5 P/Share
|
Feb 08
2022
|
Elizabeth Robinson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,043
+17.12%
|
$179,396
$172.5 P/Share
|
Feb 08
2022
|
Philip T Ruegger Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,043
+2.7%
|
$179,396
$172.5 P/Share
|
Feb 08
2022
|
Rafael Santana Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,043
+50.0%
|
$179,396
$172.5 P/Share
|
Feb 08
2022
|
Todd C Schermerhorn Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,043
+9.48%
|
$179,396
$172.5 P/Share
|
Feb 08
2022
|
Laurie J Thomsen Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,043
+1.85%
|
$179,396
$172.5 P/Share
|
Feb 08
2022
|
Bridget A Van Kralingen Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,043
+50.0%
|
$179,396
$172.5 P/Share
|
Feb 08
2022
|
Gregory C Toczydlowski EVP & President, Business Ins. |
SELL
Open market or private sale
|
Direct |
43,000
-76.49%
|
$7,353,000
$171.85 P/Share
|
Feb 08
2022
|
Gregory C Toczydlowski EVP & President, Business Ins. |
BUY
Exercise of conversion of derivative security
|
Direct |
43,000
+43.34%
|
$4,558,000
$106.03 P/Share
|
Feb 04
2022
|
Mojgan M Lefebvre EVP & Chief Tech & Ops Officer |
SELL
Open market or private sale
|
Direct |
3,115
-100.0%
|
$535,780
$172.52 P/Share
|
Feb 03
2022
|
Jeffrey P. Klenk EVP & Pres., Bond & Spec. Ins. |
SELL
Open market or private sale
|
Direct |
10,860
-72.75%
|
$1,878,780
$173.28 P/Share
|
Feb 03
2022
|
Jeffrey P. Klenk EVP & Pres., Bond & Spec. Ins. |
BUY
Exercise of conversion of derivative security
|
Direct |
10,860
+42.11%
|
$1,151,160
$106.03 P/Share
|